NDC codes

FDA NDC Directory
Product NDC (as listed)70095-019Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70095-0019Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70095-019-017009500190130 TABLET, FILM COATED in 1 BOTTLE, UNIT-DOSE (70095-019-01)Marketed from Mar 10, 2024
70095-019-0270095001902100 TABLET, FILM COATED in 1 BOTTLE (70095-019-02)Marketed from Mar 10, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Bisoprolol Fumarate
Generic name (nonproprietary)
bisoprolol fumarate
Active ingredients
Bisoprolol fumarate — 10 mg/1
Dosage form
Tablet, Film coated
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 217617
Marketing start
Listing expires
Other FDA classes
Adrenergic beta-Antagonists (Mechanism)
Identifiers
Product ID 70095-019_6ce4dc4f-ad08-424e-b90d-400de0b7050aSPL ID 6ce4dc4f-ad08-424e-b90d-400de0b7050aSPL set ID 7556f457-c4d3-49d6-b383-0ade6d489091RxCUI 854901, 854905UNII UR59KN573LUPC 0370095019011, 0370095020017
Pharmacologic class
beta-Adrenergic Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470095001901 followed by a unit qualifier and the quantity

Package 70095-0019-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Bisoprolol fumarate is indicated in the management of hypertension. It may be used alone or in combination with other antihypertensive agents.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217617

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217617
ProductStrengthForm · routeLabelerProduct NDC
Bisoprolol FumarateBisoprolol fumarate 5 mg/1TabletOralHarman Finochem Limited82638-107
Bisoprolol FumarateBisoprolol fumarate 10 mg/1TabletOralHarman Finochem Limited82638-108
Bisoprolol FumarateBisoprolol fumarate 5 mg/1Tablet, Film coatedOralPD-Rx Pharmaceuticals, Inc.72789-392
Bisoprolol FumarateBisoprolol fumarate 10 mg/1Tablet, Film coatedOralPD-Rx Pharmaceuticals, Inc.72789-395
Bisoprolol FumarateBisoprolol fumarate 5 mg/1Tablet, Film coatedOralSun Pharmaceutical Industries Limited70095-020

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in